Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1 -Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study.

Zhe HuangHuan YanLiang ZengQinqin XuWenhuan GuoShaoding LinWenjuan JiangZhan WangLi DengHaoyue QinXing ZhangFan TongRuiguang ZhangZhaoyi LiuLin ZhangXiaorong DongNong YangYong-Chang Zhang

Published in: JCO precision oncology (2023)

-rearranged NSCLCs benefit from ICI plus chemotherapy in any treatment setting, including patients who present with brain metastasis.

Keyphrases

locally advanced
resting state
cell death
dna damage
white matter
cross sectional
reactive oxygen species
multiple sclerosis
functional connectivity
radiation therapy
brain injury
chemotherapy induced
subarachnoid hemorrhage